Metabolism

Metabolism Metabolism is the set of chemical processes that sustain life by transforming nutrients into energy, macromolecules, and signaling molecules. It is central to physiology, underpins growth and homeostasis, and connects to clinical practice, public health, and evolutionary biology.

Overview and Definitions

Metabolic processes are studied across disciplines and institutions such as Harvard University, Max Planck Society, National Institutes of Health, Massachusetts Institute of Technology, and University of Oxford where researchers integrate biochemistry, molecular biology, and physiology. Classic foundational figures and works—Antoine Lavoisier, Louis Pasteur, Otto Warburg, Arthur Kornberg, Sir Hans Krebs and the Krebs cycle—shaped definitions and experimental approaches used at laboratories like Cold Spring Harbor Laboratory and museums such as the Smithsonian Institution. Definitions distinguish anabolic and catabolic reactions, often explored in textbooks from publishers like Oxford University Press and Springer Science+Business Media and taught in courses at Stanford University and University of Cambridge.

Cellular Metabolic Pathways

Cellular pathways include glycolysis, the Krebs cycle, oxidative phosphorylation, beta-oxidation, and gluconeogenesis as elucidated in classic experiments at institutions such as Max Planck Institute for Biophysical Chemistry and Salk Institute. Key enzymes (e.g., hexokinase, pyruvate dehydrogenase, ATP synthase) connect to structures characterized by techniques developed at European Molecular Biology Laboratory and National Institute of Health (United States). Metabolic intermediates link to biosynthetic pathways for nucleotides, lipids, and amino acids described in monographs from Cambridge University Press and integrated in systems studied by consortia like the Human Genome Project and Human Metabolome Database collaborators. Pathway mapping uses methods from groups at Broad Institute, employing mass spectrometry platforms pioneered at Argonne National Laboratory and imaging methods used at Lawrence Berkeley National Laboratory.

Regulation and Integration

Regulation occurs via allosteric control, covalent modification (phosphorylation by kinases studied at Cold Spring Harbor Laboratory), transcriptional regulation by factors like Hypoxia-inducible factor 1, and hormonal signals from glands such as the Pancreas and Adrenal gland. Integration across tissues (liver, skeletal muscle, adipose tissue, brain) has been explored in clinical centers including Mayo Clinic and Cleveland Clinic and in longitudinal cohorts like the Framingham Heart Study. Signaling pathways (e.g., insulin signaling, AMP-activated protein kinase) were elucidated by labs associated with Nobel Prize recipients and implemented in therapeutics developed by companies such as Pfizer and Roche. Nutrient sensing involves organelles characterized at European Molecular Biology Laboratory and networks modeled by groups at Massachusetts Institute of Technology and Princeton University.

Energy Balance and Thermodynamics

Energy balance concepts draw on thermodynamics articulated by figures and institutions such as Rudolf Clausius, James Clerk Maxwell, Royal Society, and academic programs at Imperial College London. Cellular free energy transduction via ATP, proton motive force, and redox couples was advanced by research at Max Planck Institute for Biochemistry and documented in reviews published by Nature Publishing Group and Cell Press. Whole-organism energy expenditure has been quantified in studies at facilities like National Aeronautics and Space Administration equipment and metabolic wards at Johns Hopkins Hospital; models incorporate basal metabolic rate measurements standardized by organizations such as the World Health Organization and cohorts like the Nurses' Health Study.

Metabolic Disorders and Clinical Relevance

Inherited and acquired metabolic disorders are diagnosed and managed in clinical centers including Johns Hopkins Hospital, Mayo Clinic, and university hospitals affiliated with University College London. Conditions such as diabetes mellitus, inborn errors of metabolism (e.g., phenylketonuria), nonalcoholic fatty liver disease, and mitochondrial disorders are central to research programs at institutes like National Institutes of Health and pharmaceutical research at GlaxoSmithKline. Public-health initiatives from World Health Organization and national agencies like the Centers for Disease Control and Prevention address metabolic syndrome and obesity with interventions informed by trials at institutions such as King's College London and University of California, San Francisco. Advances in precision medicine and metabolic therapeutics arise from collaborations among consortia including the 100,000 Genomes Project and companies such as Novartis.

Category:Biochemistry